CARGO Therapeutics, Inc. (NASDAQ: CRGX) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $37.00 price target on the stock.
CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director [Yahoo! Finance]
CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director
CARGO Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
CARGO Therapeutics to Participate in Upcoming Investor Conferences